ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.99
-0.47 (-3.25%)
At close: Aug 27, 2026, 4:00 PM EDT
14.27
+0.28 (2.00%)
After-hours: Aug 27, 2026, 7:54 PM EDT
ProMIS Neurosciences Employees
As of December 31, 2025, ProMIS Neurosciences had 11 total employees, including 10 full-time and 1 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$3,838,931
Market Cap
125.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | 3 | 37.50% | 10 | 1 |
| Dec 31, 2024 | 8 | 1 | 14.29% | 7 | 1 |
| Dec 31, 2023 | 7 | 0 | - | 6 | 1 |
| Dec 31, 2022 | 7 | 1 | 16.67% | 6 | 1 |
| Dec 31, 2021 | 6 | 5 | 500.00% | 5 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| Vivani Medical | 42 |
| Biomea Fusion | 37 |
| TuHURA Biosciences | 22 |
| Black Diamond Therapeutics | 21 |
| Tenax Therapeutics | 16 |
PMN News
- 6 days ago - ProMIS Neurosciences price target lowered to $29 from $30 at Roth Capital - TheFly
- 11 days ago - ProMIS Neurosciences reports Q2 EPS ($1.28), consensus ($1.90) - TheFly
- 11 days ago - ProMIS Neurosciences price target raised to $100 from $69 at Guggenheim - TheFly
- 14 days ago - ProMIS Neurosciences Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - ProMIS Neurosciences Quarterly report: Q2 2026 - Filings
- 14 days ago - ProMIS Neurosciences Earnings release: Q2 2026 - Filings
- 14 days ago - ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights - GlobeNewsWire
- 24 days ago - ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - GlobeNewsWire